Want to see MD full AI Analyst Report?
MD Stock Chart & Stats
$26.26
-$0.12(-0.46%)
At close: 4:00 PM EDT
$26.26
-$0.12(-0.46%)
Day’s Range― - ―
52-Week Range$15.70 - $27.94
Previous Close$26.14
Volume754.70K
Average Volume (3M)796.25K
Market Cap
$2.16B
Enterprise Value$2.28K
Total Cash (Recent Filing)$404.20M
Total Debt (Recent Filing)$619.96M
Price to Earnings (P/E)12.6
Beta0.63
Next Earnings
Oct 29, 2026EPS Estimate
0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.11
Shares Outstanding81,253,270
10 Day Avg. Volume793,429
30 Day Avg. Volume796,255
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)2.11
Price to Sales (P/S)0.95
P/FCF Ratio7.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$27.40Price Target Upside4.34% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)2.34
Revenue Forecast (FY)$1.96B
Bulls Say, Bears Say
Bulls Say
Cash GenerationConsistent operating and free cash flow (free cash flow roughly 90%+ of net income) gives the company durable internal funding for working capital, debt reduction, buybacks and selective investments. Strong cash conversion supports flexibility through volume cycles and funds strategic initiatives.
EBITDA Recovery & MarginsA material profitability rebound to mid-teens EBITDA margins and reaffirmed adjusted EBITDA guidance demonstrates operating leverage and execution. Margin expansion after prior losses improves resilience to revenue swings and supports sustained reinvestment, capital returns, and balance sheet repair.
Scale & Telehybrid ExpansionA broad multistate clinical footprint and investment in telehybrid services create durable competitive advantages: scale for contracting, clinical standardization, and cross-selling. Telehybrid expands addressable markets and improves cost-efficient coverage in rural and hospital-constrained markets.
Bears Say
Choppy Revenue TrendTop-line instability—periodic declines and uneven momentum—reduces visibility on sustainable growth. For a utilization-driven provider, inconsistent revenue growth complicates capacity planning, pressures per-unit economics and raises the risk that margins and cash generation could revert if volumes weaken.
Meaningful LeverageAlthough leverage has improved, remaining meaningful debt levels constrain strategic optionality and raise sensitivity to cash-flow volatility. Coverage metrics below one indicate limited cushion versus obligations, increasing refinancing and capital-allocation risk if operational performance softens.
Volume Weakness & RCM Tailwind FadingDeclining same-unit volumes and NICU utilization reduce sustainable revenue. Simultaneously, an expected fade of the RCM collections tailwind removes a near-term pricing boost, potentially slowing revenue and margin support and pressuring cash flow and leverage if not offset by volume or pricing gains.
Pediatrix Medical Group News
MD FAQ
What was Pediatrix Medical Group, Inc.’s price range in the past 12 months?
Pediatrix Medical Group, Inc. lowest stock price was $15.70 and its highest was $27.94 in the past 12 months.
What is Pediatrix Medical Group, Inc.’s market cap?
Pediatrix Medical Group, Inc.’s market cap is $2.16B.
When is Pediatrix Medical Group, Inc.’s upcoming earnings report date?
Pediatrix Medical Group, Inc.’s upcoming earnings report date is Oct 29, 2026 which is in 67 days.
How were Pediatrix Medical Group, Inc.’s earnings last quarter?
Pediatrix Medical Group, Inc. released its earnings results on Aug 04, 2026. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.591 by $0.039.
Is Pediatrix Medical Group, Inc. overvalued?
According to Wall Street analysts Pediatrix Medical Group, Inc.’s price is currently Undervalued.
Does Pediatrix Medical Group, Inc. pay dividends?
Pediatrix Medical Group, Inc. does not currently pay dividends.
What is Pediatrix Medical Group, Inc.’s EPS estimate?
Pediatrix Medical Group, Inc.’s EPS estimate is 0.65.
How many shares outstanding does Pediatrix Medical Group, Inc. have?
Pediatrix Medical Group, Inc. has 81,253,270 shares outstanding.
What happened to Pediatrix Medical Group, Inc.’s price movement after its last earnings report?
Pediatrix Medical Group, Inc. reported an EPS of $0.63 in its last earnings report, beating expectations of $0.591. Following the earnings report the stock price went down -5.867%.
Which hedge fund is a major shareholder of Pediatrix Medical Group, Inc.?
Currently, no hedge funds are holding shares in MD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Pediatrix Medical Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$27.40 (4.34% Upside)
$27.40 (4.34% Upside)
Blogger Sentiment
Neutral
MD Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 171.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
111.43%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.34%
Trailing 12-Months
Company Description
Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
MD Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented several meaningful positives: solid adjusted EBITDA ($76M), reaffirmed full-year guidance ($280M–$300M), improved payer mix and pricing, a strong balance sheet with $289M cash and low leverage (~1x), ongoing share buybacks, and strategic expansion into telehybrid services leveraging a large national footprint. Offsetting these positives are modest volume declines (same-unit volumes down 2%, NICU days down 3%), lower operating cash flow YoY, higher practice-level SW&B and G&A (including executive transition costs), and management’s expectation that the favorable RCM collections tailwind will ease in H2 2026. Overall, the call emphasized financial strength, disciplined capital allocation and strategic growth initiatives while acknowledging near-term volume and expense headwinds.View all MD earnings summariesMD Stock 12 Month Forecast
Average Price Target
$27.40
▲(4.34% Upside)
Technical Analysis
Healthcare Services
―
National Healthcare
―
―
Astrana Health
―
Aveanna Healthcare Holdings
―
Ownership Overview
1.56% Insiders
36.36% Mutual Funds
20.33% Other Institutional Investors
9.13% Public Companies and
Individual Investors